Literature DB >> 6401197

Studies on the efficacy and safety of polydioxanone monofilament absorbable suture.

E Lerwick.   

Abstract

Preclinical animal studies have clearly indicated that dyed and undyed polydioxanone monofilament absorbable sutures have prolonged breaking strength retention, a reliable absorption profile and minimal tissue reaction. The suture provides wound support throughout extended postoperative periods and is most useful in those situations in which prolonged suture integrity is desirable. Based upon these clinical studies, polydioxanone monofilament absorbable sutures must be considered as a reliable, easy to use suture material which fulfills all performance criteria. The over-all clinical results were excellent. Polydioxanone was rated as significantly superior to gut in every category evaluated. The results of this study support the claim that polydioxanone monofilament absorbable sutures are the suture of choice for general surgical use as well as in a variety of other clinical applications in which an absorbable suture is required.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401197

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  [Ligament replacement with polydioxanone (PDS)].

Authors:  K E Rehm; K H Schultheis
Journal:  Unfallchirurgie       Date:  1985-10

2.  Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent.

Authors:  Qimao Feng; Wenbo Jiang; Kun Sun; Kang Sun; Sun Chen; Lijiao Zhao; Ke Dai; Ning Ma
Journal:  J Mater Sci Mater Med       Date:  2011-08-06       Impact factor: 3.896

3.  Thread Lift in Breast Ptosis.

Authors:  Gulhima Arora; Sandeep Arora
Journal:  J Cutan Aesthet Surg       Date:  2017 Oct-Dec

4.  Modified acupuncture therapy, long-term acupoint stimulation versus sham control for weight control: a multicenter, randomized controlled trial.

Authors:  Liang Dai; Miao Wang; Ke-Pei Zhang; Lin Wang; Hui-Min Zheng; Chun-Bo Li; Wen-Jun Zhou; Shi-Gao Zhou; Guang Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.